Vibhavadi Medical Center PCL (BKK:VIBHA-R) 5-Year EBITDA Growth Rate: 7.50% (As of Mar. 2026)


BKK:VIBHA-R Vibhavadi Medical Center PCL BKK:VIBHA-R
70 GF Score
Price ฿1.36
GF Value ฿1.65
! 5 Warning Signs
View Full Analysis

What is Vibhavadi Medical Center PCL 5-Year EBITDA Growth Rate?

Vibhavadi Medical Center PCL BKK:VIBHA-R 70 5-Year EBITDA Growth Rate is 7.50% as of Mar. 2026. GuruFocus rates BKK:VIBHA-R with a GF Score™ of 70/100 and a GF Value™ of ฿1.65. The stock has 5 warning signs investors should review.

Vibhavadi Medical Center PCL's EBITDA per Share for the three months ended in Mar. 2026 was ฿0.02.

During the past 12 months, Vibhavadi Medical Center PCL's average EBITDA Per Share Growth Rate was 154.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 1.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 7.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 4.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Vibhavadi Medical Center PCL was 39.20% per year. The lowest was -15.80% per year. And the median was 13.60% per year.

Vibhavadi Medical Center PCL  (BKK:VIBHA-R) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Vibhavadi Medical Center PCL 5-Year EBITDA Growth Rate Related Terms

BKK:VIBHA-R vs HCA, THC, DVA: 5-Year EBITDA Growth Rate Comparison

For the Medical Care Facilities subindustry, Vibhavadi Medical Center PCL's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vibhavadi Medical Center PCL 5-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Vibhavadi Medical Center PCL's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Vibhavadi Medical Center PCL's 5-Year EBITDA Growth Rate falls into.


BKK:VIBHA-R
70GF Score
Vibhavadi Medical Center PCL BKK:VIBHA-R
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vibhavadi Medical Center PCL 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 7.50% mean?
Vibhavadi Medical Center PCL (BKK:VIBHA-R) has a 5-Year EBITDA Growth Rate of 7.50% as of Mar. 2026. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Vibhavadi Medical Center PCL and its competitors.
Is Vibhavadi Medical Center PCL's 5-Year EBITDA Growth Rate too high?
Vibhavadi Medical Center PCL's current 5-Year EBITDA Growth Rate is 7.50%. Overall, Vibhavadi Medical Center PCL has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Vibhavadi Medical Center PCL's 5-Year EBITDA Growth Rate compare to HCA and THC?
Vibhavadi Medical Center PCL's 5-Year EBITDA Growth Rate of 7.50% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
A good 5-Year EBITDA Growth Rate depends on the Healthcare Providers & Services industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Vibhavadi Medical Center PCL and its competitors. Vibhavadi Medical Center PCL's current 5-Year EBITDA Growth Rate is 7.50%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vibhavadi Medical Center PCL stock overvalued right now?
Vibhavadi Medical Center PCL (BKK:VIBHA-R) has a current 5-Year EBITDA Growth Rate of 7.50%. The stock's GF Value™ is ฿1.65, compared to a current price of ฿1.36 — trading 17.6% below its estimated fair value. The current 5-Year EBITDA Growth Rate is 7.50%. Vibhavadi Medical Center PCL's overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Vibhavadi Medical Center PCL (BKK:VIBHA-R), the current 5-Year EBITDA Growth Rate is 7.50% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vibhavadi Medical Center PCL (BKK:VIBHA-R) Overvalued in 2026?

Based on GuruFocus' analysis, Vibhavadi Medical Center PCL stock appears to be undervalued. The current stock price of ฿1.36 is trading 17.6% below its estimated GF Value™ of ฿1.65.

Key valuation signals for BKK:VIBHA-R:

  • 5-Year EBITDA Growth Rate: 7.50%
  • GF Value™: ฿1.65 vs. price of ฿1.36 (17.6% below fair value)
  • GF Score™: 70/100 with 5 warning signs

No single metric tells the full story. See the BKK:VIBHA-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vibhavadi Medical Center PCL Business Description

Other Exchanges VIBHA:Thailand
Address 51/3 Ngam Wong Wan Road, Latyao Sub-District, Chatuchak District, Bangkok, THA, 10900
Vibhavadi Medical Center PCL provides the medical services known as Vibhavadi Hospital. The services provided include Pediatric Diseases, General Surgery, Orthopedic Center, General Medicine, Women's Health, Gastrointestinal Center, Cardiology, Neurology, Brain Tumor Surgery, Gamma Knife Radiosurgery for Brain, Cancer, Respiratory Diseases, Plastic Surgery, ENT (Ear, Nose, Throat) Department, Dental Center, Life Style Health Screening Center, Lasik Center, Eye, Hemodialysis Department, Dermatology Center, and Other Clinics and Services. Its segments include Hospital provides general hospital and hospital in social security; and Others provide rental services and rental space. The majority of the revenue is derived from the Hospital segment.
70GF Score

Get the complete analysis for BKK:VIBHA-R

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿1.36
Price
฿1.65
GF Value